This article highlights the controversy
behind the irreproducibility of antibody research and how the use of one
antibody over another can affect the outcome of an experiment. I really don’t understand
how this is something that still exists in this day and age where science has
progressed rapidly, becoming more accurate, faster, and precise. Yet, we have
not been able to resolve this gray area of consistency and accuracy of
antibodies.
One
thing I battled with when thinking about this topic is who carries the blame
when the antibody research is irreproducible. Should the blame be placed on the
scientist who assumed that the antibody would work on its intended target or
should the blame be placed on the company who sold a product that simply did
not work?
Companies should be held accountable
when it comes to the distribution of products intended for scientific research
point blank, especially in the scope of research where peoples’ livelihood is
at stake and the price is high. At the
same time, the reality of the situation is that knockoffs are everywhere and we
should be protecting ourselves from them.
Thus, it should be the duty of the
scientist to ensure that experiments are being conducted accurately and test
the question at hand. How can you assure the validity and accuracy of an experiment
if you don't first test the validity and accuracy of the antibody? At the
same time, that scientist paid for a convenient and accurate product and that
is what they should receive-a product that works upon arrival.
I
guess my biggest turmoil with the controversy behind irreproducibility in
science is how do we deliver blame? How do we identify where or at what point
the scientific integrity of the experiment gave way? Before we can even address
this problem to fix it, we would have to choose where the blame lies : the company, the
scientist, or even the more complicated both.
No comments:
Post a Comment